source
- AstraZeneca opens 570,000-sq-ft R&D campus in Cambridge, targeting 2,000 staffAstraZeneca inaugurated a new research and development building in Cambridge, Massachusetts on Monday. The facility spans 570,000 square feet and is expected to house about 2,000 employees once fu…
- ArriVent's lead lung cancer drug firmonertinib fails Phase 3 trial, shares plungeArriVent BioPharma announced that its flagship EGFR inhibitor, firmonertinib, did not meet primary endpoints in a late-stage Phase 3 study for lung cancer. The trial results were released on Octobe…